Using magnetic stimulation to treat depression and pain together

Who could benefit from this research

What this research studies

This research investigates the use of repetitive Transcranial Magnetic Stimulation (rTMS) to treat patients suffering from Major Depressive Disorder (MDD) and fibromyalgia (FM), conditions that often occur together. The study aims to test a new rTMS protocol that targets multiple brain areas to improve both mood and pain symptoms. Patients will be randomly assigned to receive either active rTMS or a sham treatment, allowing researchers to assess the effectiveness of this approach. The goal is to provide a more effective treatment option for individuals who struggle with both depression and chronic pain.

Why it matters

Where this research is happening

• University of California Los Angeles
  Los Angeles, United States Active

Researchers

• Principal investigator: Corlier, Juliana — University of California Los Angeles
• Study coordinator: Corlier, Juliana

Related research

Other NIH-funded projects on the same topics.

• Psilocybin-Assisted ACT for Co-Occurring Cocaine Use Disorder and Major Depressive Disorder

  A new treatment combines psilocybin with Acceptance and Commitment Therapy to help people who have both cocaine use disorder and major depressive disorder.

  NIH research University of Texas Hlth Sci Ctr Houston · Houston, United States · NIH-11458025

• Single-cell study of mood-regulation brain circuits in depression

  A large study will map which genes and cell types in mood-related brain circuits are linked to major depressive disorder, including differences by ancestry and sex.

  NIH research Centre de Recherche de L'hopital Douglas · Montreal, Canada · NIH-11421431

• Single-cell map of mood circuits in major depressive disorder

  Researchers will map the tiny brain cells in mood-control areas to understand how genes and cell types relate to depression, with attention to ancestry and sex.

  NIH research Lieber Institute, INC. · Baltimore, United States · NIH-11418004

• Making genetic research clearer to find genes linked to major depression

  Researchers will use health records and genetic data to pinpoint genes that drive major depression, aiming to help people with depression get better-targeted treatments.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-11417203

• How iTBS and a brain drug could boost brain wiring to help depression

  A study tests whether a brain-stimulating treatment (iTBS) works by improving brain plasticity and whether adding a drug (DCS) enhances this effect for people with major depressive disorder.

  NIH research Mclean Hospital · Belmont, United States · NIH-11337250

• Portable, low-cost genetic test to guide antidepressant choices

  This project is creating a small, affordable device that rapidly reads genes that affect how people with major depressive disorder process antidepressants to help choose safer, more effective medicines.

  NIH research University of Virginia · Charlottesville, United States · NIH-11309190

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.